Your browser doesn't support javascript.
loading
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
Mego, M; Svetlovska, D; Chovanec, M; Reckova, M; Rejlekova, K; Obertova, J; Palacka, P; Sycova-Mila, Z; De Giorgi, U; Mardiak, J.
Afiliação
  • Mego M; Translational Research Unit, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia. misomego@gmail.com.
  • Svetlovska D; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenova 1, 833 10, Bratislava, Slovak Republic. misomego@gmail.com.
  • Chovanec M; National Cancer Institute, Bratislava, Slovak Republic. misomego@gmail.com.
  • Reckova M; Translational Research Unit, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.
  • Rejlekova K; National Cancer Institute, Bratislava, Slovak Republic.
  • Obertova J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenova 1, 833 10, Bratislava, Slovak Republic.
  • Palacka P; National Cancer Institute, Bratislava, Slovak Republic.
  • Sycova-Mila Z; National Cancer Institute, Bratislava, Slovak Republic.
  • De Giorgi U; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenova 1, 833 10, Bratislava, Slovak Republic.
  • Mardiak J; National Cancer Institute, Bratislava, Slovak Republic.
Invest New Drugs ; 37(4): 748-754, 2019 08.
Article em En | MEDLINE | ID: mdl-31152292

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Embrionárias de Células Germinativas / Antígeno B7-H1 / Anticorpos Monoclonais / Antineoplásicos Limite: Adult / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Embrionárias de Células Germinativas / Antígeno B7-H1 / Anticorpos Monoclonais / Antineoplásicos Limite: Adult / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2019 Tipo de documento: Article